AIDS is a truly global disease. As such, it raises issues that local or regional diseases do not (although some issues may be the same). For example, because AIDS affects both rich and poor countries, AIDS has become a treatable disease far more quickly than regional, poor-country diseases such as malaria. However, patented treatments for AIDS, while affordable for patients in rich countries, have not been widely available to many patients in poor countries. AIDS is also an infectious disease that is largely preventable. This means that public education and prevention measures (such as free condom distribution and needle exchange programs) are capable of slowing the spread of the disease. AIDS is also a sexually transmitted disease (although it can also be transmitted through blood transfusions, needlesharing, and mother-to-child). Many cultures have taboos about sex in general and homosexual intercourse in particular. This aspect of the disease complicates both treatment and prevention due to the stigma associated with sexually transmitted diseases. Combine such taboos with the fear associated with infectious, lifethreatening diseases, and the discriminatory treatment of marginalized members of society, and you have a potent and complex global problem that defies easy solutions.
Due to the nature of the disease itself, prevention, treatment and human rights protection must all form part of any comprehensive AIDS strategy. These are the three central issues that must be addressed simultaneously in order to deal effectively with the AIDS pandemic. Each of these issues involves a host of subsidiary issues. For example, treatment raises issues such as the cost of patented medicine, the rights of governments to suspend patent rights, the availability of health workers and infrastructure and the availability of international aid to finance national AIDS strategies. Moreover, prevention, treatment and human rights protection are inter-related issues. For example, the rights of women affect their ability to use prevention strategies. Moreover, the stigma associated with HIV/AIDS, together with a lack of legal protection against discrimination, may deter people from seeking testing and treatment. Finally, a lack of access to treatment can create a sense of futility with respect to seeking testing, which in turn can contribute to the spread of the disease.
This chapter will examine these issues in different parts of the globe. While AIDS is a global disease, its impact varies from one country to the next and from one region to the next. Variations in cultural values, affected groups, infection rates, legal systems, economic resources and human resources mean that HIV/AIDS must be considered in specific contexts. This chapter therefore seeks to paint a global picture of the AIDS pandemic one issue, one country and one region at a time, by analyzing the key issues in country-specific and region-specific contexts. The chapter ends with a consideration of how experiences with HIV/AIDS might inform the strategies adopted to address the global pandemics of the future, such as H5N1 influenza.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baldwin K (2002) Latin American AIDS Activists Turn on Brazil. Reuters, 25 May 2002
Barbour AD (1975) The Duration of the Closed Stochastic Epidemic. Biometrika 62:478, Theorem 2:478-479
Boguna M, Pastor-Satorras R, Dıaz-Guilera A, Arenas A (2003) Emergence of Cluster-ing, Correlations, And Communities In A Social Network Model. Unpublished manuscript.
Brazil Ministry of Health (2007) Boletim Epidemiológico 2007. http://www.aids.gov.br/data/Pages/LUMISE77B47C8ITEMID2814D2BBCB3A4044A05D457001332BCFPTBRI E.htm. Accessed 27 November 2007
Camacho K (2006) Latin America seeks consensual approach to AIDS/STD. Agencia Brasil
Champ P, Attaran A (2002) Patent Rights and Local Working Under the WTO TRIPS Agreement: An Analysis of the US-Brazil Patent Dispute. Yale Journal of International Law 27:365
Chartrand S (2001) Patents: In Health Emergencies, Brazil Allows the Copying of Drugs. New York Times, 19 February 2001
Cooper H, Zimmerman R, McGinley L (2001) Drug Makers’ Fight For Patent Rights Puts Them in a Vise - AIDS Suit in South Africa May Be a No-Win for Them - Industry Loses US Government’s Backing. Wall Street Journal, 5 March 2001
Cullinan K (2004) Aids Infected by toxic ideas. Financial Mail, 7 May 2004
Daly K (2000) The Business Response to HIV/AIDS: Impact and Lessons Learned. Joint United Nations Program on HIV/AIDS.
Department of Health and Ageing (2002) Return on Investment in Needle and Syringe Programs in Australia, report prepared by Health Outcomes International in association with the National Centre in HIV Epidemiology and Clinical Research and Professor Michael Drummond, Canberra
Dezso Z, Barabasi AL (2002) Halting viruses in scale-free networks. Physical Review E2002 May;65(5 Pt 2):055103. Epub 2002 May 21
Galvao J (2002) Access to Antiretroviral Drugs in Brazil. The Lancet 360:1862-1865
Gargoyles Inc. and Pro-Tec Inc. v. The United States (1997), 113 F 3d 1572.http://www.law.emory.edu/fedcircuit/may97/96-5089.htmlAccessed 20 May 2004
Garrett L (2005) HIV and National Security: Where are the Links? Council on Foreign Relations, New York.
Georgia-Pacific Corp. v. United States Plywood Corp. (1971) 318 F Supp 1116, 1120, 166 USPQ 235, 238 (SDNY), Modified and Affirmed, 446 F 2d 295, 302, 170 USPQ 369, 374 (2d Cir 1971)
Harris G (2001) Adverse Reaction: AIDS Gaffes in Africa Come Back to Haunt Drug Industry at Home - Price Cuts Abroad Deepen Domestic Trouble as Firms Reveal ‘True’ Cost of Pills - John le Carre’s New Villain. Wall Str J 23 April 2001
Health News (2007) Thai HIV Activists Scale up Protests Against AIDS Drug Blockade. http://news.monstersandcritics.com/health/news/article_1333921. php. Accessed 24 July 2007 Hughes Aircraft Co. v. United States (1996) 86 F 3d 1566, 1571-72, 39 USPQ 2d 1065, 1069 (Fed Cir 1996)
International Treatment Preparedness Coalition (2007) Missing the Target #5: Improv-ing AIDS Drug Access and Advancing Health Care for All. http://www.aidstreatmentaccess. org/itpc5th.pdf. Accessed 15 December 2007
Kaiser Daily HIV/AIDS Report (2007) Thailand Will Not Issue Compulsory Licenses for Patented Drugs if Pharmaceutical Companies Match Generic Prices, Health Minister Says. http://www.kaisernetwork.org/daily_reports/rep_index.cfm? DR_ID=44931. Accessed 18 May 2007
Kazmin A, Jack A (2007) Thailand Confirms Switch to Generic Drugs. Financial Times, 29 January 2007
Kihara M et al. (2003) HIV Surveillance in Japan 1984-2000. Journal of the Acquired Immune Deficiency Syndrome 35:S55-S63
Lanjouw J (2001) A Patent Policy Proposal for Global Diseases. The Brookings Institu-tion. http://www.brook.edu/views/papers/lanjouw/20010611.htm. Accessed 24 July 2004 Leesona Corp. v. United States (1979) 599 F.2d 958, 966, 202 USPQ 424, 432-33 (Ct. Cl. 1979)
Love J (1999) Congressional Testimony. www.house.gov/reform/cj/hearings/99.7.22/Love.htm. Accessed 24 May 2004
McNeil DG Jr (1998) AIDS Stalking Africa’s Struggling Economies. New York Times, 15 November 1998
Mindel A, Kippax S (2005) A National Sexually Transmissible Infections Strategy: The Need for an All-Embracing Approach. Medical Journal of Australia 183:10
Nemoto T (2004) HIV Surveillance and Prevention Studies in Japan. AIDS Education and Prevention, Special Supplement, June 2004, 27-42
Nemoto T et al. (2003) Potential Vector Toward High HIV Prevalence in Japan. Unpublished manuscript. University of California - San Francisco
Oliveira-Cruz V, Kowalski J, McPake B (2004) The Brazilian HIV/AIDS ‘success story’ - can others do it? Tropical Medicine and International Health 9:292-297
Petersen M (2001) Roche Asks for Meeting With Brazil Health Minister. New York Times, 24 August 2001
Rhodes T, Ball A, Stimson G et al. (1999) HIV Infection Associated with Drug Injecting in the Newly Independent States, Eastern Europe: The Social and Economic Context of Epidemics. Addiction 94:1323-1336
Rich JL (2001) Roche Reaches Accord on Drug with Brazil. New York Times, 31 August 2001
Rite-Hite Corp. v. Kelley Co (1995) 56 F 3d 1538, 1545, 35 USPQ 2d 1065, 1069 (Fed Cir) (in banc), cert denied, 116 S Ct 184
Rosenberg T (2001) Look at Brazil. New York Times, 28 January 2001
Santoro L (2007) Cheap HIV Drugs are More Important than Patents. LA Times. http://www.latimes.com/news/opinion/sunday/commentary/la-oe-santoro9 oct 09,0,7919978. story?coll=la-sunday-commentary. Accessed 9 October 2007
Shields M (2001) Drug Maker, Brazil Near Accord on AIDS Drug Price. Reuters, 23 August 2001
Sittitrai, W et al.(1992) Thai Sexual Behavior and the Risk of HIV Infection. Chulalongkorn University
Smith-Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY (2001) Community-Based Approaches to HIV Treatment in Resource-Poor Settings. Lancet 358: 404-409
Stone R (2007) Thai Health Minister Defends Controversial Drug-Patent Policy. Science 316:5830/1408
Tektronix Inc. v. United States (1977) 552 F 2d 343, 349, 193 USPQ 385, 391 (Ct Cl), modified, 557 F 2d 265 (Ct Cl 1977)
Ten Kate D (2007) Calling Mr. Condom: Thailand Renews Prevention Efforts to Stem an Uptick in HIV Infections. Asia Sentinel. http://www.asiasentinel.com/index.php?option=com_content&task=view&id=761&Itemid=31Accessed 12 October 2007
Thai Ministry of Public Health (2007) Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand. http://www.moph.go.th/hot/White%20Paper%20CL-EN.pdf. Accessed 25 November 2007
‘t Hoen E (2002) TRIPS, Pharmaceutical Patents, and Access to Essential Medicines: A Long Way From Seattle to Doha. Chicago Journal of International Law 3:27 622 HIV/AIDS Prevention and Treatment Strategies in Developed and Developing Countries.
UNAIDS (2005) On the Frontline. http://data.unaids.org/UNA-docs/Report_SHR_ OnFrontLine_18 july05_en.pdf?p. Accessed 27 June 2006
UNAIDS (2007) 2007 AIDS epidemic update. http://data.unaids.org/pub/EPISlides/ 2007/2007_ epiupdate_en.pdf. Accessed 30 November 2007
Uneklabh C et al. (1989) Prevalence of HIV Among Drug Users in Thailand. Paper Pre-sented at the Fourth International Conference on AIDS, Stockholm, Sweden
Weaver H, Smith G, Kippax S (2005) School-Based Sex Education Policies and Indica-tors of Sexual Health among young people: a Comparison of the Netherlands, France, Aus-tralia and the United States. Sex Education: Sexuality, Society and Learning 5:171-188
World Bank (2004) Project Performance Assessment Report Brazil. Report No. 28819, April 2004
Weniger BG (2006) Epidemiology of HIV Infection in Thailand, AIDS 5: S65-S71
WHO (2000) HIV, TB and Malaria - Three Major Infectious Disease Threats. Backgrounder No. 1 July 2000
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2008). HIV/AIDS Prevention and Treatment Strategies in Developed and Developing Countries. In: Global Lessons from the AIDS Pandemic. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78392-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-540-78392-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78391-6
Online ISBN: 978-3-540-78392-3
eBook Packages: Business and EconomicsEconomics and Finance (R0)